Marc N. Casper

Stories

Thermo Fisher completes nearly $9 billion acquisition of clinical trial data company Clario

Leading post-acquisition integration

Thermo Fisher Scientific, one of the world's largest scientific instrumentation companies, closed its $8.875 billion cash purchase of Clario Holdings on March 24, 2026. The deal, first announced in October 2025, includes up to $525 million in additional payments tied to Clario's near-term performance, bringing the potential total to $9.4 billion.

Updated May 30

Notable Quotes

"Clario is an outstanding strategic fit for our company, enhancing our ability to enable faster, more informed drug development through differentiated technology and data intelligence solutions." — upon announcing the deal

from Thermo Fisher completes nearly $9 billion acquisition of clinical trial data company Clario · Updated May 30

"We've long admired Clario and this acquisition underscores our disciplined capital deployment strategy, which has an outstanding track record of creating shareholder value."

from Thermo Fisher completes nearly $9 billion acquisition of clinical trial data company Clario · Updated May 30